The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells-Reference-Cited by-同舟云学术

The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells

Published:2016-04-01 Issue:4 Volume:126 Page:1603-1603
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Melillo Rosa Marina,Castellone Maria Domenica,Guarino Valentina,De Falco Valentina,Cirafici Anna Maria,Salvatore Giuliana,Caiazzo Fiorina,Basolo Fulvio,Giannini Riccardo,Kruhoffer Mogens,Orntoft Torben,Fusco Alfredo,Santoro Massimo

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference1 articles.

1. The Oncogenic Activity of RET Point Mutants for Follicular Thyroid Cells May Account for the Occurrence of Papillary Thyroid Carcinoma in Patients Affected by Familial Medullary Thyroid Carcinoma

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor microenvironment in thyroid cancer: Immune cells, patterns, and novel treatments;Head & Neck;2024-02-21

2. Tumor-associated macrophages as a potential therapeutic target in thyroid cancers;Cancer Immunology, Immunotherapy;2023-10-05

3. Coexisting CLT in PTC is an independent predictor of tumor aggressiveness for patients aged under 55: a retrospective analysis of 635 patients;BMC Endocrine Disorders;2022-03-07

4. Chasing the Target: New Phenomena of Resistance to Novel Selective RET Inhibitors in Lung Cancer. Updated Evidence and Future Perspectives;Cancers;2021-03-04

5. Top 100 Cited Articles in Thyroid Cancer: A Bibliometric Analysis;The Turkish Journal of Endocrinology and Metabolism;2021